Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Weight Loss Boost: A supplement aimed at providing metabolic support alongside your healthy lifestyle changes
Other health categories offer monthly subscriptions at various costs
Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): A double-blind, multicentre, randomised, phase 3 trial
Who should avoid using it
Filing type confirmed: BLA, not NDA Eli Lilly will submit a Biologics License Application (retatrutide is regulated as a biologic), expected Q1 2027 (shifted from the previously estimated Q4 2026)
US$ 25.60
US$ 27.52
US$ 21.06
US$ 27.29
